HEALTH● LOWJul 24 · Jul 24, 2026, 7:20 PM
Outlook gains approval for ophthalmic bevacizumab for wet AMD
Seeking Alpha Tech
Outlook has gained approval for ophthalmic bevacizumab for the treatment of wet Age-related Macular Degeneration (AMD). This signifies a new therapeutic option for the condition.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH26m agoEbola: FG confirms evacuation of Nigeria’s index patient, husband to SwitzerlandVanguard NigeriaHEALTHBREAKING35m agoEbola: Suspected index patient evacuated from Nigeria by air ambulance – ReportVanguard NigeriaHEALTH58m agoNigeria’s Index Ebola Patient, Husband Evacuated To Switzerland – PateChannels TVHEALTH1h agoCarmen Barbieri, about her health status: "Everything hit me at once"Clarín